FGFR3 GENE MUTATION
Clinical trials for FGFR3 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new FGFR3 GENE MUTATION trials appear
Sign up with your email to follow new studies for FGFR3 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat cancers in first human study
Disease control Recruiting nowThis early-stage study tests a new oral drug, TYRA-430, in people with advanced liver cancer or other solid tumors that have specific genetic changes (FGF/FGFR pathway). The main goals are to find a safe dose and check for side effects. About 100 adults will take part, and the st…
Matched conditions: FGFR3 GENE MUTATION
Phase: PHASE1 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated May 16, 2026 23:57 UTC
-
New pill targets bladder Cancer's genetic weakness
Disease control Recruiting nowThis study tests a new drug called TYRA-300 in people with a low-grade, intermediate-risk bladder cancer that has not invaded the muscle. The drug targets tumors with specific changes in the FGFR3 gene. About 90 adults will take the drug to see if it shrinks tumors and delays can…
Matched conditions: FGFR3 GENE MUTATION
Phase: PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated May 14, 2026 12:02 UTC